A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary Hypercholesterolemia

Clinical trial NCT02260635 · TERMINATED

Trial details

NCT number: NCT02260635
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia

Start date: 2014-11-01
Primary completion: 2015-07-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.